Skip to content

Author

V. K. Venuganti

We have 1 of 87 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Survivin mRNA-lipid nanoparticles promote activation of CD8+Granzyme B+ T cells and effector memory formation for effective oral cancer immunotherapy.

Effective cancer immunotherapy requires an understanding of the tumor microenvironment (TME) to overcome immune suppression and provide a durable anti-tumor response. Here, we present preclinical evaluation of survivin antigen-encoded mRNA lipid nanoparticles (mRNA-LNPs) in a murine oral cancer model. In vivo anti-tumo...

Vandana Krishna, V. K. Venuganti · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.